US approves 1st vaccine for RSV after decades of attempts
The Food and Drug Administration decision makes GSK's shot, called Arexvy, the first of several potential vaccines in the pipeline for RSV to be licensed anywhere.
The Food and Drug Administration decision makes GSK's shot, called Arexvy, the first of several potential vaccines in the pipeline for RSV to be licensed anywhere.
